Solasto Corporation (TSE:6197) sign a contract to acquire 96.63% stake in POSSIBLE Medical Science, Ltd. from West Japan Railway Company (TSE:9021) for ¥1.3 billion on May 24, 2023. Solasto Corporation will acquire 14,339 shares in POSSIBLE Medical Science. POSSIBLE Medical Science has reported revenues of ¥1.91 billion, total assets of ¥765 million, EBIT of ¥38 million, net income of ¥43 million and net assets of ¥305 million on fiscal year ended January 2023.

The board resolution date is May 24, 2023. The transaction is expected to complete on July 3, 2023.